本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

梯瓦制药

15.02
+0.15001.01%
盘前15.230.2100+1.40%04:16 EDT
成交量:1,200.58万
成交额:1.81亿
市值:172.27亿
市盈率:-10.36
高:15.45
开:15.33
低:14.81
收:14.87
数据加载中...
2020/08/05

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/08/05

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/08/05

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/08/05

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/08/05

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/08/05

重要事件披露

8-K - Current report
2020/06/19

SEC问询函

CORRESP [Cover] - Correspondence
2020/06/09

重要事件披露

8-K - Current report
2020/05/07

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/05/07

重要事件披露

8-K - Current report
2020/02/21

年度报告

Annual report [Section 13 and 15(d), not S-K Item 405]
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/12

重要事件披露

Current report, items 2.02 and 9.01
2020/02/05

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/28

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2019/11/25

重要事件披露

Current report, items 1.01, 2.03, and 9.01
2019/11/07

季度报告

Quarterly report [Sections 13 or 15(d)]
2019/11/07

重要事件披露

Current report, items 5.02 and 9.01
2019/11/07

重要事件披露

Current report, items 2.02 and 9.01
2019/11/06

持股变动声明

Statement of changes in beneficial ownership of securities